The effects of peripheral chemoreflex suppression on ventilatory efficiency and exercise duration in pulmonary arterial hypertension
European Respiratory Journal · 2024
DOI: 10.1183/13993003.00307-2024 ↗Kurz gefasst
Leserbrief in der Zeitschrift European Respiratory Journal, 2024. Verfasst von Michael J Plunkett und 5 weiteren Autor:innen. Beteiligte Einrichtung: Manaaki Manawa - The Centre for Heart Research, Department of Physiology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, N…. Hauptthemen laut MEDLINE: Exercise. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: Sidney Taylor Trust, Green Lane Research and Educational Fund, Health Research Council of New Zealand.
Abstract (Originalsprache)
Exercise intolerance is debilitating for people with pulmonary arterial hypertension (PAH), limiting their ability to undertake work, exercise, and impedes daily personal care and household tasks [1]. Dyspnoea limits exercise capacity in PAH and may arise due to ventilatory inefficiency secondary to heightened peripheral chemoreflex sensitivity ( i.e. excessive hypoxic ventilatory response) [2]. Indeed, hyperoxia, which inhibits the peripheral chemoreflex, improved ventilatory efficiency and doubled exercise duration in PAH, although results are confounded by associated improvements in skeletal muscle and cerebral oxygenation [3]. Footnotes This manuscript has recently been accepted for publication in the European Respiratory Journal . It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article. Conflicts of interest: SS declares receipt of travel grants from Janssen and Merck, and research grants from Janssen. Conflicts of interest: MJP, ALCS, JFRP and JPF have no conflicts of interest to disclose.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Manaaki Manawa - The Centre for Heart Research, Department of Physiology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
- Respiratory Medicine, Te Toka Tumai Auckland, Te Whatu Ora Health New Zealand, Auckland, New Zealand.
- Manaaki Manawa - The Centre for Heart Research, Department of Physiology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand jp.fisher@auckland.ac.nz.
ORCID-Profile: Michael J Plunkett
Förderung
- Sidney Taylor Trust
- Green Lane Research and Educational Fund
- Health Research Council of New Zealand
Zitieren
APA
Plunkett, M. J., Sayegh, A. L. C., McWilliams, T. J., Sithamparanathan, S., Paton, J. F. R., & Fisher, J. P. (2024). The effects of peripheral chemoreflex suppression on ventilatory efficiency and exercise duration in pulmonary arterial hypertension. European Respiratory Journal. https://doi.org/10.1183/13993003.00307-2024
Vancouver
Plunkett MJ, Sayegh ALC, McWilliams TJ, Sithamparanathan S, Paton JFR, Fisher JP. The effects of peripheral chemoreflex suppression on ventilatory efficiency and exercise duration in pulmonary arterial hypertension. European Respiratory Journal. 2024. doi:10.1183/13993003.00307-2024
BibTeX
@article{Plunkett2024,
author = {Plunkett, Michael J and Sayegh, Ana Luiza C and McWilliams, Tanya J and Sithamparanathan, Sasiharan and Paton, Julian F R and Fisher, James P},
title = {The effects of peripheral chemoreflex suppression on ventilatory efficiency and exercise duration in pulmonary arterial hypertension},
journal = {European Respiratory Journal},
year = {2024},
doi = {10.1183/13993003.00307-2024}
}
EUVIMED